Department of Anesthesiology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.
Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, China.
Int Immunopharmacol. 2024 Feb 15;128:111463. doi: 10.1016/j.intimp.2023.111463. Epub 2024 Jan 7.
Inflammation is an important part of the wound healing process. The stress hormone epinephrine has been demonstrated to modulate the inflammatory response via its interaction with β2-adrenergic receptor (β2-AR). However, the precise molecular mechanism through which β2-AR exerts its influence on inflammation during the wound healing process remains an unresolved question.
Transcriptome datasets of wound and macrophages from the GEO database were reanalyzed using bioinformatics. The role of β2-AR in wound healing was explored by a mouse hind paw plantar wound model, and histological analyses were performed to assess wound healing. In vivo and in vitro assays were performed to elucidate the role of β2-AR on the inflammatory response. Triggering receptor expressed on myeloid cells 1 (Trem1) was knocked down with siRNA on RAW cells and western blot and qPCR assays were performed.
Trem1 was upregulated within 24 h of wounding, and macrophage β2-AR activation also upregulated Trem1. In vivo experiments demonstrated that β2-AR agonists impaired wound healing, accompanied by upregulation of Trem1 and activation of cAMP/PKA/CREB pathway, as well as by a high level of pro-inflammatory cytokine production. In vitro experiments showed that macrophage β2-AR activation amplified LPS-induced inflammation, and knockdown of Trem1 reversed this effect. Using activator and inhibitor of cAMP, macrophage β2-AR activation was confirmed to upregulate Trem1 via the cAMP/PKA/CREB pathway.
Our study found that β2-AR agonists increase Trem1 expression in wounds, accompanied by amplification of the inflammatory response, impairing wound healing. β2-AR activation in RAW cells induces Trem1 upregulation via the cAMP/PKA/CREB pathway and amplifies LPS-induced inflammatory responses.
炎症是伤口愈合过程的重要组成部分。应激激素肾上腺素已被证明通过其与β2-肾上腺素能受体(β2-AR)的相互作用来调节炎症反应。然而,β2-AR 在伤口愈合过程中影响炎症的确切分子机制仍然是一个未解决的问题。
使用生物信息学重新分析 GEO 数据库中伤口和巨噬细胞的转录组数据集。通过小鼠后爪足底伤口模型探索β2-AR 在伤口愈合中的作用,并进行组织学分析以评估伤口愈合。进行体内和体外测定以阐明β2-AR 对炎症反应的作用。在 RAW 细胞上用 siRNA 敲低髓样细胞表达的触发受体 1(Trem1),并进行 Western blot 和 qPCR 测定。
在受伤后 24 小时内,Trem1 上调,巨噬细胞β2-AR 激活也上调 Trem1。体内实验表明,β2-AR 激动剂损害伤口愈合,同时上调 Trem1 和激活 cAMP/PKA/CREB 途径,以及高水平的促炎细胞因子产生。体外实验表明,巨噬细胞β2-AR 激活放大 LPS 诱导的炎症,并且 Trem1 的敲低逆转了这种效应。使用 cAMP 的激活剂和抑制剂,证实巨噬细胞β2-AR 激活通过 cAMP/PKA/CREB 途径上调 Trem1。
我们的研究发现,β2-AR 激动剂增加伤口中的 Trem1 表达,同时放大炎症反应,损害伤口愈合。RAW 细胞中β2-AR 的激活通过 cAMP/PKA/CREB 途径诱导 Trem1 上调,并放大 LPS 诱导的炎症反应。